| Indicators | Browse All

iShares Genomics Immunology and Healthcare ETF (IDNA)

Health | Exchange Traded Fund | NYSEArca
39.29 USD -1.31 (-3.227%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 39.29

Short-term:★★★★⯪Long-term:★★⯪☆☆Dividends:★★⯪☆☆
Hot Take | Aug. 22, 2026, 5:04 a.m. EDT

The immediate outlook is aggressively bullish, driven by a massive 13% intraday spike that pushed the price from the mid-30s to nearly 41, shattering the 52-week high. This momentum has created a high-conviction short-term entry opportunity, though the statistical forecast model remains neutral, highlighting a disconnect between recent price action and longer-term trend indicators. However, the long-term picture is mixed; while the recent rally is impressive, the asset suffers from a multi-year structural decline, having lost over 12% cumulatively since 2019 with only three positive years in the last six. The market has clearly punished the underlying business quality over the long haul, making this a classic 'mean reversion' trade rather than a fundamental buy. The dividend yield of less than 1% offers no cushion against the long-term drag, confirming that capital appreciation is the sole driver here. Investors should view this as a tactical play on the genomics sector's resurgence, not a stable core holding.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.067503
MSTL0.069452
AutoARIMA0.072415
AutoETS0.072417

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 41%
H-stat 12.33
Ljung-Box p 0.000
Jarque-Bera p 0.011
Excess Kurtosis -0.02
Attribute Value
Trailing P/E 25.25

As of Aug. 22, 2026, 5:04 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at strikes significantly below current prices (24-28 range), suggesting a fear of a sharp downside correction or volatility spike. Conversely, call activity is sparse and concentrated near-the-money or slightly in-the-money, indicating limited aggressive bullish conviction despite the recent price surge. Implied volatility is elevated on puts relative to calls, reflecting asymmetric risk pricing.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.42% 1.01% 1.15% 0.96%
Dividend History
Date Dividend Yield %
2026-06-15 0.125 0.417223
2025-12-16 0.155 0.593642
2025-06-16 0.153 0.730310
2024-12-17 0.111 0.476190
2024-06-11 0.111 0.461347
2023-12-20 0.169 0.771337
2023-06-07 0.071 0.288465
2022-06-09 0.136 0.490090
2021-12-13 0.256 0.576317
2021-06-10 0.052 0.104796
2020-12-14 0.036 0.072830
2020-06-15 0.084 0.233139
2019-12-16 0.240 0.797607
Additional Data
dividendYield 0.87

Info Dump

Attribute Value
All Time High 55.55
All Time Low 17.26
Ask 43.13
Ask Size 600
Average Daily Volume10 Day 128,370
Average Daily Volume3 Month 62,007
Average Volume 62,007
Average Volume10Days 128,370
Beta3 Year 1.12
Bid 35.58
Bid Size 1,200
Category Health
Crypto Tradeable 0
Currency USD
Custom Price Alert Confidence HIGH
Day High 40.09
Day Low 39.17
Dividend Yield 0.87
Eps Trailing Twelve Months 1.5562099
Esg Populated 0
Exchange PCX
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 34.44438
Fifty Day Average Change 4.845619
Fifty Day Average Change Percent 0.14067952
Fifty Two Week Change Percent 75.82565
Fifty Two Week High 41.49
Fifty Two Week High Change -2.2000008
Fifty Two Week High Change Percent -0.053024843
Fifty Two Week Low 22.18
Fifty Two Week Low Change 17.11
Fifty Two Week Low Change Percent 0.7714157
Fifty Two Week Range 22.18 - 41.49
First Trade Date Milliseconds 1,560,519,000,000
Five Year Average Return -0.0452076
Full Exchange Name NYSEArca
Fullday Change -1.31
Fullday Change Percent -3.22659
Fullday Price 39.29
Fund Family iShares
Fund Inception Date 1,560,211,200
Gmt Off Set Milliseconds -14,400,000
Has Pre Post Market Data 1
Language en-US
Legal Type Exchange Traded Fund
Long Business Summary The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
Long Name iShares Genomics Immunology and Healthcare ETF
Market us_market
Market State CLOSED
Max Age 86,400
Message Board Id finmb_607153959
Nav Price 40.48533
Net Assets 190,862,672.0
Net Expense Ratio 0.47
Open 40.09
Phone 415-670-2000
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 39.29
Post Market Time 1,787,959,806
Previous Close 40.6
Price Hint 2
Quote Source Name Nasdaq Real Time Price
Quote Type ETF
Region US
Regular Market Change -1.31
Regular Market Change Percent -3.22659
Regular Market Day High 40.09
Regular Market Day Low 39.17
Regular Market Day Range 39.17 - 40.09
Regular Market Open 40.09
Regular Market Previous Close 40.6
Regular Market Price 39.29
Regular Market Time 1,787,947,200
Regular Market Volume 74,451
Short Name iShares Genomics Immunology and
Source Interval 15
Symbol IDNA
Three Year Average Return 0.242271
Total Assets 190,862,672
Tradeable 0
Trailing P E 25.247236
Trailing Peg Ratio None
Trailing Three Month Nav Returns 10.32476
Trailing Three Month Returns 10.32476
Triggerable 1
Two Hundred Day Average 30.112474
Two Hundred Day Average Change 9.177526
Two Hundred Day Average Change Percent 0.3047749
Type Disp ETF
Volume 74,451
Yield 0.0087
Ytd Return 24.07149